Advisory Board

The HBA advisory board provides strategic direction on how the HBA can further the advancement of women’s careers in healthcare worldwide through HBA initiatives. The board is made up of an invited group of senior executives in the healthcare industry that represent a diverse membership and who are willing to support the HBA mission for a three-year term.

Paula Brown Stafford, adjunct professor, public health leadership 
Gillings School of Global Public Health

Carolyn Buck-Luce, managing partner 
Imaginal Labs LLC

Nick Colucci, CEO 
Publicis Health

Jennifer Cook, global head of clinical operations
Roche Pharma

Joaquin Duato, EVP and worldwide chairman, pharmaceuticals 
J&J

Lisa George, VP, global talent for international 
Walmart

Geno Germano, president  
Intrexon

Brian Goff, COO  
Neurovance

Adele Gulfo, EVP and chief strategy officer 
Mylan

Bahija Jallal, president 
MedImmune

Jacopo Leonardi, chairman and CEO  
ActivCore

Nancy Lurker, CEO and board director  
pSivida

Carol Montandon, chief quality officer, vice president, quality and compliance  
J&J

Terri Pascarelli, CEO
AIT Bioscience

Kristine Peterson, past CEO, 
Valeritas, Inc.  

Mary Pittman, DrPH, president and CEO 
Public Health Institute (PHI)

Kim Ramko, Americas advisory life sciences sector lead 
EY

Kevin Rigby, principal 
Rigby Consulting LLC

Shideh Sedgh Bina, founding partner  
Insigniam

Christi Shaw, senior vice president, Lilly, and president global bio medicines 
Eli Lilly

Stuart Sowder, PharmD, JD, MBA, vice president of external medical communications  
Pfizer, Inc

Susan Torroella, executive vice president 
Wellness Corporate Solutions, LLC

Wendy White, rare disease commercial consultant 
Wendy White Consulting

Ceci Zak, COO, healthcare  
Omnicom - DAS

Tim Zuber, partner 
KPMG